Swedish Orphan Biovitrum AB

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0000872095
SEK
383.00
2.8 (0.74%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
7,821.00
7,776.00
6,175.00
6,465.00
7,436.00
6,894.00
5,442.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
7,821.00
7,776.00
6,175.00
6,465.00
7,436.00
6,894.00
5,442.00
Raw Material Cost
2,231.00
9,040.00
2,247.00
2,400.00
2,525.00
2,175.00
2,149.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
185.00
168.00
216.00
262.00
225.00
326.00
337.00
Selling and Distribution Expenses
2,214.00
-4,850.00
1,882.00
1,776.00
2,280.00
1,809.00
1,755.00
Other Expenses
69.40
58.60
56.70
57.20
75.60
51.90
56.10
Total Expenditure (Excl Depreciation)
5,324.00
4,944.00
4,912.00
5,010.00
5,786.00
4,829.00
4,802.00
Operating Profit (PBDIT) excl Other Income
2497
2832
1263
1455
1650
2065
640
Other Income
2.00
-26.00
-16.00
-6.00
-4.00
15.00
3.00
Operating Profit (PBDIT)
3,253.00
10,321.00
2,136.00
2,387.00
2,578.00
3,004.00
1,558.00
Interest
185.00
168.00
216.00
262.00
225.00
326.00
337.00
Exceptional Items
-142.00
-6,664.00
-237.00
-92.00
15.00
-41.00
-30.00
Gross Profit (PBDT)
5,590.00
-1,264.00
3,928.00
4,065.00
4,911.00
4,719.00
3,293.00
Depreciation
754.00
7,515.00
889.00
938.00
932.00
924.00
915.00
Profit Before Tax
2,174.00
-4,027.00
794.00
1,096.00
1,437.00
1,712.00
275.00
Tax
309.00
-1,132.00
160.00
221.00
47.00
248.00
51.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,862.00
-2,895.00
636.00
875.00
1,397.00
1,464.00
224.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,862.00
-2,895.00
636.00
875.00
1,397.00
1,464.00
224.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
-2.00
0.00
-6.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,862.00
-2,895.00
634.00
875.00
1,391.00
1,464.00
224.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.55
0.55
0.55
0.55
0.55
0.55
Reserves
37,717.00
35,976.00
39,061.00
39,029.00
40,286.00
37,094.00
36,336.00
Earnings per share (EPS)
5.34
-8.4
1.83
2.52
4.03
4.22
0.65
Diluted Earnings per share
5.34
-8.4
1.83
2.52
4.03
4.22
0.65
Operating Profit Margin (Excl OI)
31.93%
36.42%
20.45%
22.51%
22.19%
29.95%
11.76%
Gross Profit Margin
37.44%
44.86%
27.26%
31.46%
31.86%
38.24%
21.87%
PAT Margin
23.81%
-37.23%
10.3%
13.53%
18.79%
21.24%
4.12%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 5.18% vs 8.65% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 33.86% vs 35.58% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 25.91% vs -0.69% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is -17.78% vs -39.68% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Swedish Orphan Biovitrum AB With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
7,821.00
184.04
7,636.96
4,149.62%
Other Operating Income
0.00
0.00
0.00
Total Operating income
7,821.00
184.04
7,636.96
4,149.62%
Raw Material Cost
2,231.00
15.06
2,215.94
14,714.08%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
185.00
4.93
180.07
3,652.54%
Selling and Distribution Expenses
2,214.00
49.45
2,164.55
4,377.25%
Other Expenses
69.40
7.99
61.41
768.59%
Total Expenditure (Excl Depreciation)
5,324.00
149.36
5,174.64
3,464.54%
Operating Profit (PBDIT) excl Other Income
2,497.00
34.68
2,462.32
7,100.12%
Other Income
2.00
9.33
-7.33
-78.56%
Operating Profit (PBDIT)
3,253.00
47.16
3,205.84
6,797.79%
Interest
185.00
4.93
180.07
3,652.54%
Exceptional Items
-142.00
0.00
-142.00
Gross Profit (PBDT)
5,590.00
168.97
5,421.03
3,208.28%
Depreciation
754.00
3.15
750.85
23,836.51%
Profit Before Tax
2,174.00
39.07
2,134.93
5,464.37%
Tax
309.00
47.90
261.10
545.09%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,862.00
-8.83
1,870.83
21,187.20%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,862.00
-8.83
1,870.83
21,187.20%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,862.00
-8.83
1,870.83
21,187.20%
Equity Capital
0
0
0.00
Face Value
0.00
0.02
0.00
Reserves
37,717.00
1,967.08
35,749.92
1,817.41%
Earnings per share (EPS)
5.34
-0.10
5.44
5,440.00%
Diluted Earnings per share
5.34
-0.10
5.44
5,440.00%
Operating Profit Margin (Excl OI)
31.93%
18.84%
0.00
13.09%
Gross Profit Margin
37.44%
22.94%
0.00
14.50%
PAT Margin
23.81%
-4.80%
0.00
28.61%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 782.10 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 0.58% vs 25.93% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 5.18% vs 8.65% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 186.20 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 164.32% vs -556.62% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 33.86% vs 35.58% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 325.10 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -68.58% vs 380.81% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 25.91% vs -0.69% in Dec 2024

Quarterly - Interest
Interest 18.50 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 10.12% vs -22.22% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -17.78% vs -39.68% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.93%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024